FDA Enforcement Class II Terminated

EDI BZO UNCUT SHEET-CARD, Item No. 100170 These Drugs of Abuse Tests are one-step immunoassays for the qualitative detection of multiple drugs and drug metabolites in human urine. The configurations of these Drugs of Abuse Tests consist of a combination of drug strips, including Benzodiazepine (BZO). They are used to obtain a visual, qualitative result and are intended for professional and point of care use.

Recall: Z-0310-2016 · Reported November 25, 2015

Enforcement

Recall Number
Z-0310-2016
Event ID
72471
Classification
Class II
Status
Terminated
Product Type
Devices
Firm
Ameditech Inc
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
Letter
Report Date
November 25, 2015
Initiation Date
October 20, 2015
Classification Date
November 18, 2015
Termination Date
November 9, 2016
Address
9940 Mesa Rim Rd, N/A, San Diego, CA, 92121-2910, United States

Description

EDI BZO UNCUT SHEET-CARD, Item No. 100170 These Drugs of Abuse Tests are one-step immunoassays for the qualitative detection of multiple drugs and drug metabolites in human urine. The configurations of these Drugs of Abuse Tests consist of a combination of drug strips, including Benzodiazepine (BZO). They are used to obtain a visual, qualitative result and are intended for professional and point of care use.

Reason

Ameditech is recalling drug abuse tests because they have shown reduced reactivity.

Code Info

134268 134898 140206 140218 140453 140551 141053 141129 143471 143553 144468 144557 150317 150531 150606 150638 150834 151154 152021 152104 134067 134504 140495 141010 141128 141197 143716 143784 143866 144003 144042 144199 144270 144332 144443 144502 144555 150237 150347 150440 150901 150989 151239 151925 151984 152003 152103

Distribution

Worldwide Distribution - US (nationwide) and Internationally to Australia.

Quantity

70364 units